|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2099489 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07761925.2 |
| Date of filing the European patent application | 2007-05-04 | |
| (97) | Date of publication of the European application | 2009-09-16 |
| (45) | Date of publication and mention of the grant of the patent | 2014-05-21 |
| (46) | Date of publication of the claims translation | 2014-08-25 |
| (86) | Number | PCT/US2007/068300 |
| Date | 2007-05-04 |
| (87) | Number | WO 2008/073509 |
| Date | 2008-06-19 |
| (30) | Number | Date | Country code |
| 874460 P | 2006-12-11 | US |
| (72) |
MASS, Robert, D., US
PLOWMAN, Gregory, D., US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080-4990,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kompozicijos ir būdai, skirti neoplazmos gydymui |
| COMPOSITIONS AND METHODS FOR TREATING A NEOPLASM |
| Payment date | Validity (years) | Amount | |
| 2019-04-29 | 13 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-05-04 |